About Alloy Therapeutics
Alloy Therapeutics is a private company based in Waltham, Massachusetts. It has reported $146,764,637 raised in three offerings on Form D since April 2021. Its chief executive is Errik Anderson.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Apr 15, 2026 | $30,020,259of $39.9M target | 11 | $2.7M | EquityRule 506(b) | Form D ↗ |
| Sep 16, 2022 | Oct 3, 2022 | $41,744,503fully sold | 13 | $3.2M | EquityRule 506(b) | Form D ↗ |
| Mar 19, 2021 | Apr 2, 2021 | $74,999,875fully sold | 17 | $4.4M | Equity, OptionsRule 506(b) | Form D ↗ |
| Total, three offerings | $146,764,637 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Alloy Therapeutics's Form D filed Apr 15, 2026.
AS
Anthony Sun
Director
AH
Alaa Halawa
Director
UN
JC
JC
Jason Coloma
Director
CK
Christian Kanady
Director
AK
Alex Kolicich
Director
LS
Earlier filings also listed Fabian Hansen (director, last listed Oct 2022) and Jay Rosanelli (executive officer, last listed Apr 2021).